Pharmacists authorized to initiate, prescribe, administer, and dispense drugs for the treatment of opioid use disorder; and grounds for disciplinary action for pharmacists and pharmacist interns modified.
Received from House; Introduction and first reading; Referred to
Email me when HF 4493 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HF 4493. By continuing you agree to the Terms and Privacy Policy.
Summary
The measure expands the definition of "practitioner" to include pharmacists who treat opioid use disorder, and adds new authority for them to prescribe, dispense and give Schedule III‑V drugs for that purpose after required training and DEA registration. It also updates the statutory description of pharmacy practice and clarifies disciplinary grounds for pharmacists and interns. The bill failed to pass.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HF 4493
3 free questions a day, no accountHistory
- Referred to Health and Human Services
- Received from House
- Introduction and first reading
- Third reading
- Bill was passed
- House rule 1.21, placed on Calendar for the Day 04/27/2026
- Second reading
- Committee report, to adopt
- Author added Rehrauer
- Introduction and first reading, referred to Health Finance and Policy
Sponsors
- Baker · sponsor
- Hoffman
- Rehrauer
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HF 4493 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HF 4493 freeOr ask your AI assistant about HF 4493 directly:
Add to Claude, ChatGPT or Cursor